Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
Targher G, Day CP, Bonora E. Targher G, et al. N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063. N Engl J Med. 2010. PMID: 20879883 Review. No abstract available.
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Targher G, et al. Diabetologia. 2008 Mar;51(3):444-50. doi: 10.1007/s00125-007-0897-4. Epub 2007 Dec 6. Diabetologia. 2008. PMID: 18058083
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.
Ballestri S, Lonardo A, Romagnoli D, Carulli L, Losi L, Day CP, Loria P. Ballestri S, et al. Liver Int. 2012 Sep;32(8):1242-52. doi: 10.1111/j.1478-3231.2012.02804.x. Epub 2012 Apr 22. Liver Int. 2012. PMID: 22520641 Clinical Trial.
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Targher G, Bertolini L, Rodella S, Lippi G, Franchini M, Zoppini G, Muggeo M, Day CP. Targher G, et al. Obesity (Silver Spring). 2008 Jun;16(6):1394-9. doi: 10.1038/oby.2008.64. Epub 2008 Mar 27. Obesity (Silver Spring). 2008. PMID: 18369343
How to Diagnose Nonalcoholic Fatty Liver Disease.
de Alwis NM, Anstee QM, Day CP. de Alwis NM, et al. Dig Dis. 2016;34 Suppl 1:19-26. doi: 10.1159/000447277. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27547937
Nonalcoholic fatty liver disease.
Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-Tetri BA, Rinella ME. Brunt EM, et al. Nat Rev Dis Primers. 2015 Dec 17;1:15080. doi: 10.1038/nrdp.2015.80. Nat Rev Dis Primers. 2015. PMID: 27188459 Review.
Nonalcoholic fatty liver disease: new treatments.
Hardy T, Anstee QM, Day CP. Hardy T, et al. Curr Opin Gastroenterol. 2015 May;31(3):175-83. doi: 10.1097/MOG.0000000000000175. Curr Opin Gastroenterol. 2015. PMID: 25774446 Free PMC article. Review.
Non-alcoholic fatty liver disease: a massive problem.
Day CP. Day CP. Clin Med (Lond). 2011 Apr;11(2):176-8. doi: 10.7861/clinmedicine.11-2-176. Clin Med (Lond). 2011. PMID: 21526706 Free PMC article. Review. No abstract available.
Elevated endotoxin levels in non-alcoholic fatty liver disease.
Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Harte AL, et al. J Inflamm (Lond). 2010 Mar 30;7:15. doi: 10.1186/1476-9255-7-15. J Inflamm (Lond). 2010. PMID: 20353583 Free PMC article.
251 results
Jump to page